Skip to content
Shameless Cloning

Search Shameless Cloning

Search superinvestors, stocks, insiders and members of Congress

Q3 2026 13F · SEC CIK 1731216

Martin Capital Partners, LLC

Wealth managerFiled 2026-10-07 for Q3 2026. Open the filing ↗ · All SEC filings ↗

Reported 13F value
$279.1M
Reported positions
73
Top holdings a year, 3 yrs
+13.3%
Assets under management
$290.5M

Martin Capital Partners, LLC is a wealth manager that reported 73 positions worth $279.1M in its Q3 2026 13F, filed 2026-10-07. Its largest holdings were Amgen Inc (AMGN, 4.6%), Johnson & Johnson (JNJ, 4.0%), Cullen Frost Bankers Inc (CFR, 3.8%). A portfolio copying its top holdings returned 13.3% a year over the last 3 years, against 20.4% for the S&P 500.

Martin Capital Partners, LLC holdings largest 50 of 73 positions.

Weights are shares of the filer's total reported 13F value, compared with Q2 2026. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.

Martin Capital Partners, LLC 13F holdings
Stock% of 13F valueShare changeReported value
AMGNAmgen Inc4.6%+0.4%$12.9M
JNJJohnson & Johnson4.0%-0.1%$11.1M
CFRCullen Frost Bankers Inc3.8%+0.4%$10.7M
CMECme Group Inc3.8%+1.3%$10.6M
CVXChevron Corporation3.6%+0.3%$10.2M
MSFTMicrosoft Corp3.6%-3.3%$10.1M
ASMLAsml Hldg NV3.4%+1.2%$9.5M
CSCOCisco Sys Inc3.2%-3.2%$9.0M
XOMExxonmobil Holdings Corp3.2%—$8.9M
BKHBlack Hills3.1%+0.2%$8.6M
RGAReinsurance Group America2.9%+0.1%$8.0M
TXNTexas Instrs Inc2.8%-1.5%$7.7M
JPMJpmorgan Chase & Co2.7%-2.1%$7.7M
PGProcter & Gamble Co2.6%+0.3%$7.4M
UNPUnion Pac Corp2.5%+0.1%$7.0M
GDGeneral Dynamics Corp2.5%-0.6%$7.0M
ULUnilever PLC2.3%-0.1%$6.5M
KOFCoca-Cola Femsa Sab de Cv2.2%-0.3%$6.1M
MDTMedtronic PLC2.2%+0.9%$6.1M
DVNDevon Energy Corp New2.2%+0.0%$6.1M
JKHYHenry Jack & Assoc Inc Com2.1%+0.3%$5.9M
ORealty Income Corp.2.1%+0.6%$5.9M
TROWPrice T Rowe Group Inc2.1%-0.6%$5.8M
TTETotalenergies SE2.0%+0.2%$5.5M
PFEPfizer Inc2.0%+1.9%$5.5M
SPSBSpdr Series Trust1.9%+1.9%$5.3M
PAYXPaychex Inc1.9%+0.1%$5.3M
VZVerizon Communications Inc1.9%+1.0%$5.2M
PEPPepsico Inc1.9%+0.9%$5.2M
PORPortland Gen Elec Co1.7%+0.0%$4.8M
ETREntergy Corp New1.7%-0.1%$4.7M
IGSBIshares Tr1.7%+1.6%$4.6M
PEGPublic Svc Enterprise Group1.6%+0.1%$4.6M
NVONovo-Nordisk A S1.6%-0.8%$4.5M
CLXClorox Company1.4%+1.4%$3.8M
SHYIshares Tr1.3%+2.0%$3.7M
HDHome Depot Inc1.2%-0.1%$3.4M
MKCMccormick & Co Inc1.2%+2.8%$3.3M
STIPIshares Tr1.2%+0.8%$3.2M
NKENike Inc1.0%-0.2%$2.8M
PFGPrincipal Financial Group in0.4%-3.5%$1.2M
DGXQuest Diagnostics Inc0.4%-2.3%$1.1M
IEIIshares Tr0.4%+4.6%$1.1M
CORCencora Inc0.3%+9.7%$957K
AAPLApple Inc0.3%+0.0%$950K
MSMMsc Indl Direct Inc0.3%-2.4%$930K
SCHDSchwab Strategic Tr0.2%+4.2%$681K
LECOLincoln Elec Hldgs Inc0.2%-2.7%$628K
SDYSpdr Ser Tr0.2%+2.7%$592K
INGRIngredion Inc0.2%+8.4%$535K

What Martin Capital Partners, LLC bought and sold in Q3 2026, against Q2 2026.

New positions

Q2 2026's filing was too long to tell new positions apart.

Added to

Reduced

No position shrank by more than 5%.

Left the top 50

Share counts compared with the Q2 2026 13F; a split also changes share counts. The latest filing lists more than 50 positions, so a position that left the top 50 may still be held.

How the holdings did against the S&P 500.

1 year
+28.4% /yr
S&P 500 +20.1%
3 years
+13.3% /yr
S&P 500 +20.4%
5 years
+7.5% /yr
S&P 500 +11.6%

A portfolio of the filer's 20 largest 13F positions, weighted by value, bought the trading day after each 13F was filed and held until the next one was: what copying this filer could have earned. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.

Reported 13F value by quarter.

13F value by quarter
Quarter13F valuePositions
Q3 2026$279.1M73
Q2 2026$272.0M72
Q1 2026$269.1M68
Q4 2025$265.8M70
Q3 2025$257.8M70
Q2 2025$255.1M75
Q1 2025$83.6M58
Q4 2024$84.3M58
Q3 2024$202.4M69
Q2 2024$247.6M71
Q1 2024$260.7M69
Q4 2023$245.3M70

Questions about Martin Capital Partners, LLC's portfolio

What stocks does Martin Capital Partners, LLC own?

Martin Capital Partners, LLC's latest 13F, for Q3 2026 and filed Oct 7, 2026, lists 73 positions worth $279.1M. The largest are Amgen Inc (AMGN) at 4.6%, Johnson & Johnson (JNJ) at 4.0%, Cullen Frost Bankers Inc (CFR) at 3.8%, Cme Group Inc (CME) at 3.8% and Chevron Corporation (CVX) at 3.6%.

What did Martin Capital Partners, LLC buy last quarter?

In Q3 2026, Martin Capital Partners, LLC added Cencora Inc (COR) (+9.7% shares) and Ingredion Inc (INGR) (+8.4% shares), compared with its Q2 2026 filing.

What did Martin Capital Partners, LLC sell last quarter?

In Q3 2026, Martin Capital Partners, LLC cut from its top 50 Phillips 66 (PSX), compared with its Q2 2026 filing.

How has Martin Capital Partners, LLC's portfolio performed?

A portfolio copying Martin Capital Partners, LLC's 20 largest 13F holdings each quarter, from the day each filing was public, returned +13.3% a year over the last 3 years, against +20.4% for the S&P 500. Over 1 year: +28.4% against +20.1%. Over 5 years: +7.5% a year against +11.6%.

When is Martin Capital Partners, LLC's next 13F filing due?

13F filings are due 45 days after each quarter ends. Martin Capital Partners, LLC's filing for the quarter ending Dec 31, 2026 is due by Feb 14, 2027; this page updates the day after it is published.

How much money does Martin Capital Partners, LLC manage?

Martin Capital Partners, LLC reported $290.5M of regulatory assets under management on its latest SEC Form ADV. Its 13F, which covers only US-listed stocks and options, totals $279.1M.